---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-22-001335"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T15:00:22.723966+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BioSig raises ~$1.45M in equity at $0.41/share; warrant repricing generates additional $218K

## Summary
- Sold 3,541,469 shares at $0.41 each to accredited investors for aggregate proceeds of $1,452,000.
- Reduced March Warrants exercise price from $1.40 to $0.25 for a limited window; 510,000 shares issued for $127,500.
- Total proceeds from offering and warrant exercises combined are $1,670,250.
- Warrant pricing reduction applied only through November 10, 2022; total March Warrants exercised to date: 873,000 shares.

## SEC filing metadata
- accession: 0001185185-22-001335
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518522001335/0001185185-22-001335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518522001335/biosig20221121_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-22-001335
- JSON: https://secwatch.observer/filing/0001185185-22-001335.json
- Plain text: https://secwatch.observer/filing/0001185185-22-001335.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,452,000 (effective 2022-11-18).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: $1,452,000
  - Effective: 2022-11-18
  source text: On November 18, 2022, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 3,541,469 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.41 per share, in exchange for aggregate consideration of $1,452,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518522001335/0001185185-22-001335-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.